NEW YORK Researchers at Cornell University concluded that the cost of cancer drugs has dwindled in the past 10 years.
The study, "A Quality-Adjusted Price Index for Colorectal Cancer Drugs," analyzed the treatment data collected through clinical software and developed a price index for cancer treatments between 1993 and 2005, according to a report. Overall, the researchers found that the true cost of cancer drugs is 30% less than a decade ago.
"Instead of focusing on the cost of a specific drug dosage cost, cancer or otherwise, it is essential that we look at the big picture costs that include all aspects of quality of life," said Peggy C. Frank, MBA CEO, Frank Public Relations Worldwide, Westlake Village, Calif.
The findings were published by National Bureau of Economic Research.